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Experimental evidence suggests that sleep restriction increases energy intake (EI) and may alter 
energy expenditure (EE). However, it is unknown whether the timing of a sleep restriction period 
impacts EI and EE the following day. Hence, we examined the effects of sleep restriction with an 
advanced wake-time or delayed bedtime on next day EI and EE. Twelve men and 6 women (age: 
23 ± 4 years, body fat: 18.8 ± 10.1%) participated in 3 randomized crossover sessions: control 
(habitual bed- and wake-times), 50% sleep restriction with an advanced wake-time and 50% 
sleep restriction with a delayed bedtime. Outcome variables included sleep architecture 
(polysomnography), EI (food menu), total EE and activity times (accelerometry). Carbohydrate 
intake was greater on day 2 in the delayed bedtime vs. control session (1386 ± 513 vs. 
1579 ± 571 kcal; P = 0.03). Relative moderate-intensity physical activity (PA) time was greater 
in the delayed bedtime session vs. control and advanced wake-time sessions on day 1 
(26.6 ± 19.9 vs. 16.1 ± 10.6 and 17.5 ± 11.8%; P = 0.01), whereas vigorous-intensity PA time 
was greater following advanced wake-time vs. delayed bedtime on day 1 (2.7 ± 3.0 vs. 
1.3 ± 2.4%; P = 0.004). Greater stage 1 sleep (β = 110 kcal, 95% CI for β = 42 to 177 kcal; 
P = 0.004), and a trend for lower REM sleep (β = − 20 kcal, 95% CI for β = − 41 to 2 kcal; 
P = 0.07), durations were associated with greater EI between sleep restriction sessions. These 
findings suggest that the timing of a sleep restriction period impacts energy balance parameters. 
Additional studies are needed to corroborate these findings, given the increasing prevalence of 
shift workers and incidences of sleep disorders and voluntary sleep restriction. 
 






Borbély [1] suggested that sleep is regulated by 2 overlapping processes: the homeostatic sleep 
drive (or process “S”) and the circadian rhythm (or process “C”). The homeostatic sleep drive 
(process “S”) promotes the occurrence of slow-wave sleep (SWS) as the amount of this sleep 
stage is greatly influenced by the length of prior wakefulness [2]. Conversely, REM sleep is 
mainly influenced by the circadian rhythm (process “C”) and is more common during the second 
part of the night when core temperature is reduced and hypothalamic-pituitary-adrenal (HPA) 
axis activity and cortisol release are greater [3]. Sleep restriction protocols [4], [5] comparing 
sleep architecture when anchoring the sleep period during the first or second half of the night 
reported no differences in SWS between sleep restriction protocols, whereas REM sleep was 
greater during sleep held the second half of the night. Stage 2 sleep duration was consequently 
reduced as a result of maintained SWS and greater REM sleep durations during this time. 
 
Studies have reported mean increases of ≈ 300–500 kcal over 24 h following an imposed sleep 
restriction condition vs. a control condition (habitual sleep duration) [6], [7], [8], [9], [10], [11]. 
However, the effects of imposed sleep restriction on energy expenditure (EE) are not as 
consistent; some studies reported no changes in EE inside a lab/inpatient clinic [8], [12] and 
under free-living conditions [11], whereas others reported either greater [7] or lower [13] EE 
following similar sleep restriction protocols (1–2 nights of 4 h in bed/night). Studies have also 
reported negative associations between SWS duration and energy intake (EI) the following day 
under habitual sleep conditions [14], as well as negative associations between changes in SWS 
and REM sleep with changes in carbohydrate and fat intakes between a habitual and partial sleep 
restriction condition [15]. Finally, Gonnissen et al. [16] reported greater post-dinner desire to eat 
ratings following 1 night of fragmented sleep, which caused a significant reduction in REM, but 
not SWS time, compared to 1 night of non-fragmented sleep (control condition). 
 
Taken together, these studies suggest that reduced sleep duration increases EI and may affect EE. 
However, it is unknown whether imposed alterations in sleep timing, in addition to reduced sleep 
duration, have an effect on EI and EE the following day. The primary objective of the present 
study was to evaluate the effects of a 50% sleep restriction with an advanced wake-time or 
delayed bedtime on EI and EE over 36 h. The secondary objective was to assess the strength of 
the associations between changes in sleep architecture with changes in next day EI and EE 
between sessions. It was hypothesized that sleep restriction with an advanced wake-time would 
lead to greater EI coupled with lower EE and moderate-to-vigorous physical activity (PA) time. 
It was also hypothesized that these changes in EI and EE would be associated with changes in 
REM sleep between the control and advanced wake-time sessions. 
 




Eighteen participants (12 men and 6 women) completed all sessions. Participants were between 
the ages of 18–45 years, non-smokers, weight stable (± 4 kg) within the last 6 months, did not 
have heart problems or diabetes, did not take medication which may affect appetite or sleep, and 
reported not performing shift work nor taking regular daytime naps. All participants reported 
having habitual sleep durations of 7–9 h/night. Only women taking monophasic combined 
estrogen-progesterone birth control were recruited to control for sex-steroid hormone effects on 
sleep parameters [17] and EI [18]. This study was conducted according to the guidelines laid 
down in the Declaration of Helsinki and the University of Ottawa ethics committee approved all 
procedures involving human participants. Written informed consent was obtained from all 
participants. 
 
2.2. Design and procedures 
 
Participants took part in a preliminary session followed by 2 weeks of sleep-wake monitoring 
with accelerometry and sleep diaries, an in-lab habituation night followed by a recovery night at 
home, and 3 experimental sessions. Fig. 1 presents an overview of the sleep protocol for each 
experimental session. A washout period of at least 7 days separated each experimental session. 
Participants were instructed not to consume alcohol or exercise for at least 24 h prior to the 
preliminary and experimental sessions. They were also asked not to consume caffeinated 
products after 12 h00 (noon), and to wash their hair in order to facilitate electrode installation on 
the day of each experimental session. Lastly, participants were asked if they felt well rested at 
the start of each experimental session. Compliance to these instructions was verified by self-
report at the start of each session. 
 
 
Fig. 1. Overview of the sleep protocol applied during each experimental session. 
A) Control session; B) Sleep restriction with an advanced wake-time; C) Sleep restriction with a delayed bedtime 
*Based on 2 weeks of accelerometry data. 
 
2.3. Preliminary session 
 
Participants arrived at the lab at 8 h00 following an imposed 12 h overnight fast. At this time, 
height, body weight and body composition were measured. Participants were then provided 
with ad libitum quantities of the following foods for breakfast: whole-wheat toast (D'Italiano®; 
4 slices), strawberry jam (Smuckers®; 60 g), peanut butter (Kraft Smooth Peanut Butter®; 60 g), 
cheddar cheese (Cracker Barrel Marble Cheddar Cheese®; 42 g) and orange juice (Tropicana®; 
500 g). They were given 15 min to eat as much or as little as they wanted. The measured quantity 
and composition of the consumed breakfast was provided to them during each experimental 
session, and they were instructed to consume the breakfast in its entirety during these sessions. 
Hence, the energy content and composition of the breakfast varied between participants, but 
were constant across sessions for the same participant. To assess habitual chronotype and 
degrees of daytime sleepiness, participants completed the Horne-Ostberg Morningness-
Eveningness Questionnaire [19] and the Epworth sleepiness scale [20], respectively. Participants 
with extreme morning or evening chronotypes (scores ≥ 70 and ≤ 30, respectively) (n = 0) and/or 
frequent feelings of daytime sleepiness (score ≥ 10) (n = 1) were excluded from further study 
participation. Lastly, participants were asked to wear an accelerometer (SenseWear Pro 3 
Armbands©, HealthWear Bodymedia, Pittsburgh, PA, USA) and to complete a sleep diary over 
2 weeks to assess habitual sleep patterns (bedtime, wake-time, sleep duration and sleep 
efficiency). Participants were excluded from further participation if they had a mean sleep 
efficiency [(sleep time/total time in bed) ∗ 100] over 2 weeks < 80% (n = 1). These data were 
also used to tailor the experimental interventions to each participant, and to better capture inter-
individual representations of habitual sleep patterns. 
 
2.4. Experimental sessions 
 
All participants took part in 2 habituation nights, which included an in-lab session during which 
the entire polysomnography (PSG) set-up was performed, followed by a recovery night at home. 
The first in-lab habituation night was used to exclude participants with sleep disorders 
(e.g. restless leg syndrome, sleep apnea), and to provide an adaptation to the experimental 
settings used for in-lab sleep assessment. No participants were excluded based on detected sleep 
disorders, but 1 participant was excluded from further testing because of a very low sleep 
efficiency during this session (sleep efficiency in this instance was ≈ 20%). 
 
Following this session, participants took part in 3 randomized crossover sessions: control 
(habitual bed- and wake-times), 50% sleep restriction with a habitual bedtime and advanced 
wake-time and 50% sleep restriction with a delayed bedtime and habitual wake-time. Each 
session followed the same protocol and differed only in the amount of total time in bed, and the 
assigned bed- or wake-time. Since the assigned bed- and wake-times slightly differed between 
participants (range for bedtime: 22 h16-24 h40, wake-time: 6 h18-8 h37), the time at which each 
test was administered also differed according to this same range between participants, but 
remained the same for each participant across sessions. Participants were evenly randomized for 
the order of experimental sessions (i.e. 6 participants started with each of the 3 experimental 
sessions). Participants arrived at the lab 3 h prior to their set bedtime to allow enough time to 
place the electrodes (≈ 90 min), set up the polysomnogram (≈ 30 min) and allow for some 
downtime before bedtime (≈ 60 min). When forced to remain awake during the night and the 
following morning, participants took part in sedentary activities (e.g. reading, watching movies), 
and remained inside the lab with the researchers. Upon awakening, participants took a shower. 
Prior to breakfast consumption, which was set at the same time during each session, body weight 
was measured. Participants also had access to an ad libitum lunch, which was consumed inside 
the lab before being given ad libitum quantities of self-selected food items in packed containers 
for the remainder of the day (day 1; upon leaving the lab until midnight or ≈ 18 h) and the 
following day (day 2; midnight to midnight or 24 h) [21], along with an accelerometer to wear 
for this same time period. Lastly, they were asked to bring back the remaining food and all 
containers, along with the accelerometer, within the few days following the end of data 
collection. 
 
2.5. Anthropometric measurements 
 
Standing height was measured, without shoes, to the nearest centimeter using a Tanita HR-100 
height rod (Tanita Corporation of America Inc., Arlington Heights, IL, USA). Body weight and 
body composition (body fat %) were measured using a standard beam scale (HR-100; BWB-
800AS, Tanita Corporation, Arlington Heights, IL, USA) and DXA scanner (Lunar Prodigy, 
General Electric, Madison, WI, USA), respectively. Standing height and body composition were 
only measured during the preliminary session, whereas body weight was measured prior to 
breakfast during the 3 experimental sessions. 
 
2.6. Sleep assessment and sleepiness ratings 
 
Sleep was recorded using EEG (C3, C4, O1, O2, F3 and F4), EMG (bipolar submental) and EOG 
on a Medipalm 22 (Braebon Medical Corporation, Kanata, Ontario, Canada), with the Pursuit 
Sleep Software (Braebon Medical Corporation, Kanata, Ontario, Canada) inside the lab. Inferior 
tibialis EMG and naso-oral thermistor signals were also recorded during the in-lab adaptation 
night. All PSG recordings were scored independently by 2 judges according to the AASM [22] 
criteria using 30-s epochs; discrepancies were resolved by mutual agreement. The following 
sleep variables were extracted: total sleep duration in minutes (from sleep onset to wake-time, 
minus wake after sleep onset), sleep latency (elapsed time between the set bedtime and 10 min of 
stage 1 or 20 s of any other sleep stage), % of sleep efficiency [(sleep time/time in bed) ∗ 100], 
wake after sleep onset (WASO) in minutes, as well as the absolute amount of time spent in each 
sleep stage (stages 1 and 2 sleep, SWS and REM sleep). 
 
Feelings of sleepiness were assessed prior to bedtime, immediately upon awakening and 30 min 
post-awakening with a 100-mm computerized visual analogue scale [23] with the following 
question: “How sleepy do you feel?” (Alert/not sleepy at all - very sleepy/sleep onset soon). 
 
2.7. Ad libitum energy intake 
 
Ad libitum energy and macronutrient intakes were measured with a validated food menu [21]. 
This food menu is a list of 62 different items (e.g. lasagna, chicken stir-fry, 6 choices of fruits 
and vegetables, milk, chips, chocolate). Participants were asked to select the food items from this 
menu that they may want to consume during lunch (consumed inside the lab), the remainder of 
that day (end of the session to midnight; consumed outside the lab), and the entire following day 
(midnight to midnight; consumed outside the lab). Two portions of each selected food item was 
prepared, weighed and served (inside the lab) or packed into separate containers/bottles and 
placed into a cooler for the participants to bring home with them for the remaining 36 h of 
measurements (outside the lab). Participants were asked to bring the remaining food 
items/leftovers, wrappings and containers back to the lab following the end of this measurement 
period. The remaining items following the in-lab lunch and out-of-lab measurements were 
weighed, and the energy and macronutrient intakes of the participants for both days across 
sessions were determined and analyzed with the Food Processor SQL software (version 9.6.2; 
ESHA Research). Standard breakfast intake, in-lab lunch and EI for the remainder of the day 
(end of session to midnight) were combined, and provided energy and macronutrient intake 
values for day 1. Energy and macronutrient intakes for day 2 were measured from midnight to 
midnight the following day. One participant did not bring back all food containers at the end of 1 
session; hence, the results of 17 participants are presented herein for day 1 and day 2 energy and 
macronutrient intakes. 
 
2.8. Out-of-lab energy expenditure and activity times 
 
Participants were given a biaxial accelerometer (SenseWear Pro 3 Armbands©, HealthWear 
Bodymedia, Pittsburgh, PA, USA) prior to leaving the lab during each experimental session, and 
were instructed to wear the accelerometer at all times, including when sleeping. The 
accelerometer was placed around the upper arm (mid-distance between the acromion and the 
olecranon). The SenseWear Professional software (version 7.0, Bodymedia, Pittsburgh, PA, 
USA) was used to retrieve the data once the accelerometer was returned to the lab. Collected 
data included: total EE (kilocalories), sedentary time (minutes; < 3 METs), moderate-intensity 
PA time (minutes; 3–6 METs), vigorous-intensity PA time (minutes; > 6 METs) and estimated 
sleep time (minutes). Estimated bed- and wake-times, sleep duration and sleep efficiency on 
night 2 (outside the lab; following PSG and in-lab assessments) were also computed from this 
device. This device showed overall intraclass correlations above 0.8 when comparing EE 
with doubly-labeled water [24] and sleep parameters with PSG [25], thus indicating good 
agreement when assessing these variables with this tool. 
 
2.9. Statistical analyses 
 
Statistical analyses were performed using SPSS (version 17.0; SPSS Inc., Chicago, IL, USA). 
One-way repeated measures ANOVA tests (for normally distributed data) and the Friedman 
Exact non-parametric test (for non-normally distributed data according to the Shapiro Wilk test) 
were used to determine the main effects of sleep condition on body weight, in-lab sleep variables 
(sleep duration, sleep efficiency and absolute sleep stage durations), energy and macronutrient 
intakes (days 1 and 2), EE (days 1 and 2), activity time (sleep, waking sedentary, moderate- and 
vigorous-intensity; days 1 and 2) and sleepiness ratings. Relative sleep stage duration (%) was 
compared between both sleep restriction conditions with a paired sample t-test since the 
prescribed sleep durations for these sessions were identical. Since significant differences in 
accelerometer wear time were noted on day 2 (1273 ± 173, 1372 ± 78, 1363 ± 97; P = 0.01; 
partial η 2 = 0.23), the EE per minute of wear time (kilocalories/min), as well as the relative 
activity times (%) were compared between sessions. The Wilcoxon Signed Ranks Test was used 
as a post-hoc test to assess potential differences between sessions for variables that were not 
normally distributed according to the Shapiro-Wilk test. For normally distributed data, post-
hoc tests with LSD adjustments were used to determine where significant differences existed. 
Linear regression models were computed to assess the strength of the associations between 
changes in absolute sleep stage durations with changes in EI and EE on day 1 between sessions. 
Sex, age and delta sleep duration between the compared sessions were added as covariates to 
these models. Values are presented as means ± standard deviations. Differences with P-values 




3.1. Participant characteristics, in-lab sleep assessment and sleepiness ratings 
 
Participant characteristics are presented in Table 1. No significant differences in body weight 
were noted between sessions (69.2 ± 9.2, 69.4 ± 9.3, 69.2 ± 9.4; P = 0.72; partial η 2 = 0.02), a 
crude indication of energy balance maintenance. Table 2 presents the sleep parameters measured 
with PSG and accelerometry during each session. Sleep duration was lower during the advanced 
wake-time vs. delayed bedtime condition. Sleep efficiency (overall and after sleep onset) was 
greater during the delayed bedtime session vs. the control and advanced wake-time sessions. 
Stages 1 and 2 sleep durations were higher, and REM sleep duration was lower, during the 
advanced wake-time vs. delayed bedtime condition. SWS was only higher during the control vs. 
advanced wake-time condition. When comparing relative sleep stage time between both sleep 
restriction conditions, stages 1 and 2 sleep durations were higher, and REM sleep duration lower, 
during the advanced wake-time vs. delayed bedtime condition. No differences were noted 
between relative SWS between sleep restriction conditions. Lastly, sleepiness ratings were 
higher prior to bedtime when it was delayed, and upon awakening in both sleep restriction 
conditions vs. control. 
 
Table 1. Participant characteristics (n = 18).  
Mean ± SD Range 
Age (years) 23 ± 4 18–33 
Body mass index (kg/m2) 22.7 ± 2.7 19–30 
Body fat (%) 18.8 ± 10.1 8–48 
Standard breakfast intake (grams) 500 ± 147 257–742 
Standard breakfast intake (kcal) 779 ± 240 427–1109 
Carbohydrate intake (kcal) 406 ± 121 192–612 
Fat intake (kcal) 292 ± 110 136–495 
Protein intake (kcal) 109 ± 34 56–170 
Total score on the Epworth Sleepiness scales (0 − 10) 6 ± 2 3–9 
Total score on the Horne-Ostberg Morning-Eveningness 
Questionnaire (30–70) 
54 ± 8 37–64 
Habitual time in bed (min)* 490 ± 38 437–582 
Habitual sleep efficiency [(sleep time/total time in bed) * 
100] (%)* 
86 ± 4 80–91 (n = 16 < 90%; n = 2 ≥ 90%) 
Habitual sleep efficiency [(sleep time/time in bed after 
sleep onset and before wake time) * 100] (%)* 
91 ± 4 83–96 (n = 6 < 90%; n = 12 ≥ 90%) 
Habitual bedtime (24-h clock) 23 h27 ± 37 min 22 h17-24 h40 
Habitual wake-time (24-h clock) 7 h37 ± 38 min 6 h18-8 h37 
Habitual sleep timing midpoint (24-h clock) 3 h32 ± 32 min 2 h40-4 h25 
*Based on data collected for 14 days with accelerometry. 
Note: kcal, kilocalories; SD, standard deviation. 
 
  
Table 2. In-lab (polysomnography) and out-of-lab (accelerometry) sleep parameters during each 







Mean ± SD Mean ± SD Mean ± SD P-value; 
partial η 2⁎ 
In-lab (polysomnography) 
Sleep duration (min) 463 ± 30a 229 ± 17b 236 ± 17c P = 0.0001; 
partial η 2 = 0.99 
Sleep efficiency [(sleep time/total time in bed) * 
100] (%) 
95 ± 3a 93 ± 4a 97 ± 2b P = 0.001 
Sleep efficiency [(sleep time/time in bed after sleep 
onset) * 100] (%) 
96 ± 2a 96 ± 3a 98 ± 1b P = 0.004 
Stage 1 sleep (min) 18 ± 10a 7 ± 4b 4 ± 3c P = 0.0001; 
partial η 2 = 0.66 
Stage 2 sleep (min) 245 ± 35a 113 ± 29b 101 ± 31c P = 0.0001; 
partial η 2 = 0.95 
SWS (min) 92 ± 32a 76 ± 33b 80 ± 31a P = 0.03; partial 
η 2 = 0.20 
REM sleep (min) 108 ± 24a 34 ± 7b 51 ± 17c P = 0.0001; 
partial η 2 = 0.91 
Stage 1 sleep (%) NA** 2.9 ± 1.5a 1.8 ± 1.0b P = 0.01; partial 
η 2 = 0.36 
Stage 2 sleep (%) NA** 47.6 ± 12.5a 41.9 ± 13.0b P = 0.02; partial 
η 2 = 0.28 
Stage 3 sleep (%) NA** 31.8 ± 14.2a 33.1 ± 12.9a P = 0.52; partial 
η 2 = 0.03 
REM sleep (%) NA** 14.2 ± 2.9a 21.3 ± 7.1b P = 0.0001; 
partial η 2 = 0.59  
Sleepiness ratings (0 − 100) 
Prior to bedtime 65 ± 14a 63 ± 22a 83 ± 16b P = 0.001 
Upon awakening 44 ± 26a 68 ± 20b 60 ± 25b P = 0.001 
30 min post-awakening 22 ± 16a 51 ± 19b 45 ± 26b P = 0.0001; 
partial η 2 = 0.46  
Out-of-lab (accelerometry) 
Sleep duration (min) 466 ± 64a 512 ± 81a 488 ± 131a P = 0.16 
Sleep efficiency [(sleep time/time in bed) * 100] (%) 87 ± 4a 88 ± 6a 90 ± 5a P = 0.16; partial 
η 2 = 0.10 
Sleep efficiency [(sleep time/time in bed after sleep 
onset and before wake time) * 100] (%) 
92 ± 4a 94 ± 5a 94 ± 4a P = 0.34; partial 
η 2 = 0.06 
Bedtime (24-h clock) 23 h23 ± 1h16a 22 h40 ± 55mina 23 h37 ± 1h38a P = 0.14 
Wake-time (24-h clock) 7 h57 ± 1h29a 8 h09 ± 1h37a 8 h19 ± 1h34a P = 0.70; partial 
η 2 = 0.02 
Note: Means not sharing the same letter are significantly different from each other (P < 0.05). 
*Partial η 2 were not available for variables that were compared using the Friedman Exact non-parametric test. 
**It is not possible to compare relative sleep stage time (%) between the control and sleep restriction conditions 
because of the differences in prescribed time in bed between these conditions. 
REM, rapid eye movement; SWS, slow-wave sleep; SD, standard deviation. 
 
3.2. Energy intake and energy expenditure 
 
Table 3 presents data for energy and macronutrient intakes, in addition to relative EE and activity 
times from accelerometry on days 1 and 2. No differences in energy and macronutrient intakes 
were noted for day 1. Greater carbohydrate intakes, along with a trend for increased EI, were 
noted during the delayed bedtime vs. control session on day 2. A trend for greater EE on day 1 
during the delayed bedtime vs. control session was also noted. Vigorous-intensity PA time was 
higher during the advanced wake-time vs. delayed bedtime session on day 1. Moderate-intensity 
PA time was higher during the delayed bedtime compared to the advanced wake-time and 
control sessions on day 1. No differences in sedentary and sleep times were noted between 
sessions for days 1 and 2, nor were there significant differences in sleep parameters assessed 
with accelerometry outside of the lab. 
 
Table 3. Ad libitum energy and macronutrient intakes (n = 17), as well as relative energy 





Main effect analysis 
 
Mean ± SD Mean ± SD Mean ± SD P value; partial η2 
Total energy intake - Day 1 (kcal) 2686 ± 765a 2768 ± 825a 2844 ± 735a P = 0.42; partial η 2 = 0.05 
Carbohydrate intake (kcal) 1507 ± 442 a 1544 ± 496 a 1623 ± 483 a P = 0.33; partial η 2 = 0.07 
Fat intake (kcal) 854 ± 304 a 874 ± 313 a 870 ± 238 a P = 0.92; partial η 2 = 0.01 
Protein intake (kcal) 385 ± 139 a 401 ± 130 a 411 ± 126 a P = 0.32; partial η 2 = 0.07 
Total energy expenditure - Day 1 (kcal/min) 2.2 ± 0.6 a 2.3 ± 0.5 a 2.5 ± 0.9 a P = 0.05; partial η 2 = 0.16 
Vigorous-intensity time (%) 1.6 ± 2.3a, b 2.7 ± 3.0a 1.3 ± 2.4b P = 0.004 
Moderate-intensity time (%) 16.1 ± 10.6a 17.5 ± 11.8a, b 26.6 ± 19.9b P = 0.01; partial η 2 = 0.24 
Sedentary time (%) 73.0 ± 13.1 a 66.4 ± 16.9 a 62.3 ± 18.4 a P = 0.06; partial η 2 = 0.07 
Sleep time (%) 9.3 ± 6.2 a 13.4 ± 10.9 a 9.8 ± 11.7 a P = 0.61 
Total energy intake - Day 2 (kcal) 2345 ± 816a 2534 ± 783a 2658 ± 899a P = 0.05; partial η 2 = 0.17 
Carbohydrate intake (kcal) 1386 ± 513a 1453 ± 440a 1579 ± 571b P = 0.04; partial η 2 = 0.18 
Fat intake (kcal) 649 ± 291a 755 ± 316a 743 ± 281a P = 0.10; partial η 2 = 0.13 
Protein intake (kcal) 354 ± 138a 377 ± 142a 385 ± 145a P = 0.44; partial η 2 = 0.05 
Total energy expenditure – Day 2 (kcal/min) 2.0 ± 0.5 a 2.1 ± 0.3 a 2.2 ± 0.6 a P = 0.23 
Vigorous-intensity time (%) 0.9 ± 1.2a 1.1 ± 2.1a 1.1 ± 1.5a P = 0.14 
Moderate-intensity time (%) 12.6 ± 9.3a 12.6 ± 7.3a 16.6 ± 10.0a P = 0.53 
Waking sedentary time (%) 52.3 ± 6.0a 51.6 ± 9.5a 48.6 ± 13.1a P = 0.45; partial η 2 = 0.05 
Sleep time (%) 35.0 ± 7.8a 34.0 ± 7.1a 33.7 ± 8.7a P = 0.99 
Note: Means not sharing the same letter are significantly different from each other (P < 0.05). 
kcal, kilocalories; SD, standard deviation. 
 
3.3. Linear regression model results 
 
Greater stage 1 sleep duration was associated with greater day 1 EI between both sleep 
restriction conditions in the adjusted linear regression model (β = 110 kcal, 95% CI for β = 42 to 
177 kcal; P = 0.004). A trend was also noted for increased EI on day 1 with lower REM sleep 
duration between both sleep restriction conditions (β = − 20 kcal, 95% CI for β = − 41 to 
2 kcal; P = 0.07). Identical results were noted when assessing the strength of the associations 
between changes in relative (%) stage 1 and REM sleep durations with EI between sleep 
restriction conditions on day 1. No other significant associations were noted between changes in 




To our knowledge, this is the first study to examine the effects of an imposed sleep restriction 
combined with altered bed- or wake-times on objective measures of EI and EE with a 
randomized crossover design. This study also used 2 weeks of accelerometry data for each 
participant to personalize the bed- and wake-times for the experimental sessions, which offers 
optimal control over inter-individual variations in circadian rhythms. This may in part explain 
the relatively high in-lab sleep efficiency values observed in this study. Collectively, our results 
suggest that carbohydrate intake on day 2 was greater following sleep restriction with a delayed 
bedtime compared to the control session. Additionally, moderate-intensity PA time was greater 
on day 1 during the delayed bedtime vs. advanced wake-time and control sessions, whereas 
vigorous-intensity PA time was greater on day 1 following sleep restriction with an advanced 
wake-time vs. sleep restriction with a delayed bedtime. These results do not support our initial 
hypothesis. The changes in EI and EE between the control and advanced wake-time sessions 
were not associated with changes in REM sleep duration, thus refuting our second hypothesis. 
However, when comparing both sleep restriction conditions, greater stage 1 sleep, in addition to 
a trend for lower REM sleep, durations were associated with greater EI the next day (day 1). This 
is the first study to report associations between changes in sleep architecture with next day EI 
and EE between sleep restriction conditions. 
 
Many experimental studies reported greater 24 h EI following sleep restriction vs. control 
sessions [6], [7], [8], [9], [10], [11]. Studies also reported increased intakes of all [10] or specific 
macronutrients, such as fats [11] or carbohydrates [9], following partial sleep restriction vs. 
habitual sleep duration. Although sleep timing was not evaluated in these studies, the majority 
employed longer-term (≈ 2–14 nights) sleep restriction conditions, which may explain the greater 
differences in EI between conditions. A study conducted by Brondel et al. [7] also imposed 1 
night of partial sleep restriction, compared to 1 night of habitual sleep duration, and reported 
greater EI following partial sleep restriction. The present study did not observe a significant 
difference in EI between sessions on day 1, but did note greater carbohydrate intake on day 2 
following partial sleep restriction with a delayed bedtime. Although a mere hypothesis, it is 
possible that the environment in which EI was measured (in-lab vs. outside the lab), and some of 
the restrictions imposed with regards to meal intake inside the lab (standardized breakfast and 
fixed meal times inside the lab) may have decreased the number of opportunities for spontaneous 
or increased EI on day 1. Similarly, the present study did not permit EI during the time forced to 
remain awake during the sleep restriction sessions. If ad libitum EI would have been permitted 
during these overnight hours, EI would have most likely been higher. Indeed, greater 24 h EI 
following imposed sleep restriction in previous studies were often characterized by greater late 
night and/or post-dinner snack intake during the sleep restriction condition [9], [10], [12]. Hence, 
the timing of EI under free-living conditions should be monitored in future studies, as this may 
help further explain the sleep-EI link [26]. 
 
Relative moderate-intensity PA time was greater during the delayed bedtime vs. advanced wake-
time and control sessions, whereas relative vigorous-intensity PA time was higher following 
sleep restriction with an advanced wake-time vs. delayed bedtime. The only other study to note 
greater PA participation following imposed partial sleep restriction [7] reported that this increase 
in PA participation occurred when no restrictions in PA choices were imposed on participants. In 
the present study, PA participation was only measured when participants left the lab and no 
limitations on their PA choices were imposed. However, they were instructed not to go to bed 
until their habitual bedtime on the evening following each sleep manipulation. It is possible that 
these participants resorted to PA following sleep restriction to combat feelings of fatigue during 
the day that immediately followed the sleep manipulations (day 1). A meta-analysis by 
Puetz [27] revealed that PA participation was associated with a reduced risk of experiencing 
feelings of low energy and fatigue in habitually active vs. sedentary adults. Considering that this 
study's sample included mostly active individuals (i.e. ≈ 15–23% of total time spent performing 
moderate-vigorous intensity PA), resorting to PA participation to alleviate feelings of fatigue and 
maintain wakefulness until their habitual bedtime may be seen as a viable solution for these 
participants. Studies comparing energy balance measurements in individuals with habitually 
high- vs. low-levels of PA participation following sleep restriction with altered sleep timing are 
needed to investigate this hypothesis. 
 
The linear regression models conducted revealed that greater stage 1 sleep, in addition to a trend 
for lower REM sleep, durations were associated with greater EI the next day (day 1) between 
both sleep restriction conditions. A study by Shechter et al. [15] reported significant inverse 
associations between relative stage 2, SWS and REM sleep durations with EI between a habitual 
and partial sleep restriction condition [15]. Although no cause-and-effect associations can be 
drawn from the present findings, it is possible that participants with greater amounts of 
restorative sleep (i.e. less stage 1 and more REM sleep) may be able to exert greater control over 
food intake, even though total sleep time is reduced by 50%. These findings also suggest that 
inter-individual differences in sleep quality in response to imposed sleep restriction may impact 
EI differently the next day. Further characterization of individuals by evaluating personality 
traits, morning-evening preference [28] and/or differences in cognitive inhibition [29] following 
sleep restriction are needed, as these may be strong moderators of changes in EI following sleep 
restriction. 
 
The present findings are limited to a small sample size of healthy, physically active adults with 
habitually high sleep efficiencies. This limits generalizability to other populations, including 
individuals with sleep complaints or sleep disorders. Biaxial accelerometry provides an 
estimation of sleep-wake activities. The use of doubly-labeled water in conjunction with a 
triaxial accelerometer and PSG on the 2nd night would have provided more precise 
measurements of sleep and waking activities, including physical activity participation. The 
assessment of sleep with PSG and all outcome variables were only conducted for 1 night and 
36 h post-intervention in each condition, which does not account for day-to-day variations, and 
limits the comparison of results with studies imposing prolonged sleep restrictions. Lastly, PA 
and EI were not permitted during the time that participants were forced to remain awake inside 
the lab, which may have attenuated some of the effects of sleep restriction on EI and EE. Future 
studies with similar objectives and designed to allow for ad libitum access to food and exercise 
during the overnight hours/time forced to remain awake are needed to add to these results. 
 
In conclusion, sleep restriction with a delayed bedtime led to greater carbohydrate intake, 
whereas relative moderate-vigorous PA time was greater following both sleep restriction 
sessions. Future studies are needed to further investigate sleep architecture and energy balance 
parameters in individuals with sleep disorders (e.g. insomnia, sleep apnea), as individuals with 
sustained poor sleep quality and/or reduced sleep duration may be at an increased risk of weight 
gain over time [30]. This information would be invaluable given the increasing prevalence of 
individuals experiencing regular circadian misalignment as a result of shift work, in addition to 
an increase in the incidences of sleep disorders and voluntary sleep restriction [31]. 
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